Introduction

Explor Foods Foodomics

EFF

Exploration of Foods and Foodomics

2837-9020

Open Exploration Publishing

10.37349/eff.2025.101070

101070

Review

From botany to bedside: a review of the health benefits of Lycium barbarum as a functional food

Berisha

Alois

Investigation Writing—original draft Writing—review & editing ¹

https://orcid.org/0000-0003-2833-2552

Alexa

Elena-Alexandra

Investigation Writing—original draft Writing—review & editing Supervision ¹

https://orcid.org/0000-0002-5724-9793

Kelleher

Robbie

Investigation Writing—original draft Writing—review & editing ²

https://orcid.org/0000-0003-1079-5364

Zhang

Tao

Conceptualization Investigation Writing—original draft Writing—review & editing Supervision ¹ ^* Iriti

Marcello

Academic Editor Milan State University, Italy

¹School of Food Science & Environmental Health, Technological University Dublin, Grangegorman, Dublin 7, D07 ADY7, Dublin, Ireland ²School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02 R590, Dublin, Ireland

^* Correspondence: Tao Zhang, School of Food Science & Environmental Health, Technological University Dublin, Grangegorman, Dublin 7, D07 ADY7, Dublin, Ireland. tao.zhang@tudublin.ie

2025

25 01 2025

101070

10 11 2024 20 12 2024

This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Native to East Asia and predominantly cultivated in regions such as the Ningxia Hui and Xinjiang Uyghur Autonomous Regions of China, Lycium barbarum (L. barbarum), commonly known as goji berry, has a long history in traditional medicine and is gaining recognition in contemporary health research. This review provides a comprehensive exploration of its botanical characteristics, pharmacokinetics, and safety, alongside a critical evaluation of human clinical studies investigating its therapeutic potential. Key health benefits include immune modulation, antioxidative effects, mental health support, ocular health preservation, and metabolic and cardiovascular regulation. Furthermore, its role in addressing age-related macular degeneration and chronic conditions such as cancer and metabolic syndrome is highlighted. The bioactivity of L. barbarum is attributed to its rich composition of polysaccharides, carotenoids, flavonoids, and other bioactive compounds, which exhibit anti-inflammatory, neuroprotective, and metabolic-regulating properties. This review also examines the safety profile of L. barbarum, considering its side effects, toxicity, potential contamination, and interactions with medications, emphasising the importance of balancing its health-promoting properties with cautious consumption. Despite promising findings, gaps in the evidence base, including the need for larger, long-term, and rigorously controlled trials, remain significant barriers to clinical translation. By integrating traditional medicinal knowledge with modern scientific insights, this review underscores L. barbarum’s potential as a functional food and therapeutic agent. Its unique pharmacological properties and broad applicability position it as a valuable tool for health promotion and disease prevention, while highlighting areas requiring further research to optimise its safe and effective use.

Lycium barbarum goji berry traditional Chinese medicine health functional food human studies pharmacokinetics safety

Introduction

The genus Lycium, comprising 97 species globally, of which 31 species purposed in food and medicine applications, belongs to the Solanaceae family, which also includes well-known crops like potatoes, tomatoes, peppers, and eggplants [1]. Among these species, Lycium barbarum (L. barbarum), Lycium chinense (L. chinense), and Lycium ruthenicum (L. ruthenicum) are particularly valued for their medicinal properties and functional food applications [2]. L. barbarum, commonly known as goji, is a deciduous woody shrub that is often characterised by its thorny branches. Predominantly found in East Asia, particularly in South China, Korea, and Japan, this species has been cultivated for over 600 years. Today, L. barbarum accounts for nearly 90% of the goji berries in the market [3]. Its fruits are highly valued for their rich nutritional content and numerous health benefits. L. barbarum is highly valued for its rich composition of micro- and macronutrients with notable biological activities. It is abundant in bioactive compounds such as polysaccharides, polyphenols, carotenoids, and dietary fibres, while also containing significant amounts of essential vitamins (e.g., thiamine, nicotinic acid, and riboflavin) and minerals (e.g., manganese, copper, magnesium, and selenium). These constituents contribute to the recognised health-promoting properties of L. barbarum [4]. Moreover, studies have shown that goji fruits contain essential mineral nutrients that exceeding 15% of the recommended daily allowances set by the Food and Nutrition Board (FNB). This nutrient profile highlights their potential as functional ingredients for use in diverse food and pharmaceutical formulations [5].

Botanical profile

The botanical name L. barbarum was first assigned by the botanist Carolus Linnaeus in 1753 [6]. The fruits of L. barbarum, commonly known as Ningxia goji berry or wolfberry, have gained global recognition as a “superfood” due to their rich nutritional value. Various parts of the plant, including the root, fruit, and leaf, have been utilised in traditional medicine for their health-promoting properties [7].

L. barbarum and L. chinense are closely related species, both commonly referred to as red goji or red wolfberry. However, L. barbarum is particularly known for producing larger and sweeter fruits, while L. ruthenicum, or black goji, is distinguished by its dark-coloured berries [8], which derive their deep hue from anthocyanins, potent antioxidants, associated with various health benefits [9]. These berries are also rich in a branched arabinogalactan protein, which further enhances their antioxidant properties and therapeutic potential [10]. The fruits of L. barbarum are red or orange-yellow, oblong in shape, and contain between 4 to 20 seeds. The plant’s flowers feature a 1–2 cm pedicel, a 4–5 mm campanulate calyx, typically 2-lobed, and a corolla tube 8–10 mm in length. L. barbarum can grow to a height of 0.8–2 m, with thorny branches and lanceolate or long elliptic leaves that are grey-green, ranging in diameter from 25–50 mm [11–13].

The historical use of L. barbarum dates back over 4,000 years, with its earliest mention in the ancient text “Shen Nong Ben Cao Jing” (The Classic of Herbal Medicine), written between 200 and 250 AD. Since the early 20th century, the plant has been commonly referred to as goji, derived from the Chinese term “Gou Qi” [13]. Classified under the division Magnoliophyta, class Magnoliopsida, and family Solanaceae, L. barbarum is also known by several traditional vernacular names, including boxthorn, Chinese wolfberry, and matrimony vine, especially when referring to L. barbarum or L. chinense [14, 15].

Geographic distribution

China is the largest producer of goji berries worldwide, accounting for approximately 95,000 tonnes annually, with L. barbarum being the most widely cultivated variety. The majority of these plantations are located in the Ningxia Hui Autonomous Region and the Xinjiang Uyghur Autonomous Region [16]. Other varieties, such as L. chinense, are also cultivated and distributed across East Asia, including South China, Korea, and Japan [17]. While Asian countries dominate global production, the exact origin of L. barbarum remains uncertain. It is, however, believed to have originated around the Mediterranean basin [8].

Ecology

L. barbarum thrives in soils with an optimal pH range of 6.8 to 8.1 [18]. Although it is cultivated in arid to semi-arid regions across the world, including Africa, North and South America, and Eurasia [19], the plant favours moderately moist conditions and well-drained soils. Environmental factors such as rainfall, temperature, and soil salinity significantly influence the plant’s chemical composition and the concentration of its bioactive compounds [20, 21]. The harvesting season for L. barbarum typically spans from late summer to autumn. After harvesting, the fruits are initially dried in shaded areas until their skin begins to shrink. Then they are exposed to sunlight until the outer skin fully dries and hardens [11, 22].

Historical and traditional uses

Traditionally, various parts of Lycium plants, including the fruit, leaves, young shoots, and root bark, have been utilised for both medicinal and functional food purposes [22]. In traditional Chinese medicine (TCM), these plants have been credited with beneficial effects on a range of conditions and diseases, such as diabetes, asthma, and nervous fatigue, and are believed to enhance vision and nourish vital organs like the liver and kidneys [1, 23]. As a food source, L. barbarum berries are commonly consumed in dried form or incorporated into various food products, such as yogurt, tea, and granola [24].

Methodological design

The methodology used to formulate this article included reviewing published reports from various databases (from inception to 03 June 2024, without language restrictions): Scopus, PubMed, Google Scholar, ISI Web of Science, and CNKI to maximise the retrieval of relevant results. We considered both review and original research articles involving L. barbarum studies. The search keywords for screening the literature information were: “Lycium barbarum”, “L. barbarum”, or “goji berries” in combination with “health”, “diseases”, and “safety”. The database search was supplemented by consulting the bibliography of the articles, reviews, and published meta-analyses. The literature research was not limited to a time period, but a particular focus was given to the studies from the past 20 years. Relevant articles were chosen after reviewing all titles and abstracts. Full texts were further examined if the information contained in the title or abstract was insufficient to exclude the study. The Figures included in this review were created using Microsoft PowerPoint. Icons and photos were sourced from the authors’ own collection, Microsoft, and Wikimedia Commons. Specifically, one image in Figure 2 was obtained from Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Lycium_barbarum_-_Wolfberries_on_vine.jpg), which is in the public domain.

Pharmacokinetics

In the pharmacological landscape, the complex composition of L. barbarum has garnered attention due to their diverse therapeutic applications, particularly influenced by their pharmacokinetic profiles. The recent findings provide an in-depth perspective on the exploration of the absorption, distribution, metabolism, and excretion (ADME) processes taken place due to primary constituents present in L. barbarum berries, mainly L. barbarum polysaccharides (LBPs), polyphenols, carotenoids, tropane alkaloids, and others. Studies showed that the adsorption kinetics of LBPs found in L. barbarum berries significantly dictate their efficacy, being transported via the bloodstream to various tissues [25]. For example, fluorescein isothiocyanate labelling was used to quantify the levels of LBPs in in vivo models, showing moderate bioavailability in different organs [25–27]. Upon ingestion, polysaccharides undergo partial enzymatic hydrolysis in the gastrointestinal tract, rapidly converting into lower molecular weight sugars that can be absorbed. For instance, levels of LBPs labelled with fluorescein isothiocyanate were detected in the small intestine (121.78 µg/g), stomach (76.53 µg/g), liver (26.01 µg/g), and kidney (10.57 µg/g) within one hour following oral administration [26]. After 6 h, polysaccharide concentrations increased in the kidney (83.1 µg/g), large intestine (43.34 µg/g), and liver (29.97 µg/g); while decreasing in the small intestine (13.17 µg/g) and stomach (31.50 µg/g) compared to the one-hour measurements [26]. The increased concentration of LBPs reached its peak after 24 h of administration, primarily identified in the liver. Similarly to the previous study [28], this suggests a higher preference for the liver, and the detrimental effect on the kidney could be related to the larger pore size of the capillary wall of the mice’s kidney [26].

A pharmacokinetic tracking study reported that LBPs are not easily absorbed in the body and are slowly eliminated through urine and faeces, with a cumulative excretion rate of 92.27% within 72 h after 50 mg/kg LBPs intake [27], thus indicating a longer stagnation in the large intestine.

Carotenoids such as zeaxanthin and β-carotene [29] are absorbed in the small intestine. Their lipophilic nature would require the presence of dietary fats in the small intestine for effective absorption, as they are incorporated into micelles made from dietary lipids and bile acids [30]. Hempel et al. [31] demonstrated that the addition of coconut lipids (1%) boosted the release of zeaxanthin from L. barbarum berries by 89% compared to intake without fats in an in vitro digestion model. Whereas LBPs would prefer immune-related organs, in contrast, carotenoids were predominantly distributed to the liver and eyes [31]. The high affinity of zeaxanthin for the macular region is particularly notable, as it is critical in filtering harmful high-energy blue light and quenching free radicals [31]. Carotenoids undergo oxidative cleavage by the enzyme carotenoid dioxygenase, producing vitamin A and other smaller metabolites that play essential roles in vision, growth, and immune function [32]. Notably, when ingested, zeaxanthin is minimally metabolised, which might explain its significant accumulation in fatty tissues, but more predominantly in the macula [11].

Excretion patterns of L. barbarum bioactive compounds vary, with LBPs primarily excreted via the kidneys in their monosaccharide forms [11]. In contrast, carotenoids are mainly eliminated through faeces as part of the bile and exhibit a longer elimination time, which can take up to 7 days [32].

The detailed ADME characteristics of L. barbarum phytochemicals suggest their substantial roles in preventative and therapeutic health applications. Understanding these pharmacokinetic properties is essential for optimising dietary recommendations and therapeutic dosages, particularly in developing nutraceutical products aimed at enhancing immune function and protecting against oxidative stress-related diseases.

Human clinical studies

Recent human studies highlight the therapeutic potential of L. barbarum across a range of health conditions, including its role in immune support, antioxidant enhancement, mental health, and the management of ocular, metabolic, and cardiovascular disorders, as well as certain cancers and non-alcoholic fatty liver disease (NAFLD). L. barbarum’s multifaceted health benefits are illustrated in Figure 1, demonstrating its impact on specific physiological processes associated with these conditions. Table 1 provides a summary of the clinical studies conducted to date, highlighting key outcomes and reinforcing L. barbarum’s promise as a functional food with diverse health applications.

Figure 1

Health benefits of Lycium barbarum for various conditions

Table 1

Summary of clinical studies on the effects of Lycium barbarum (goji berry) supplementation on health conditions

Conditions	Study design	Participant information	Key findings	Reference
General well-being, neurologic/psychologic traits, gastrointestinal function	Randomised, double-blind, placebo-controlled, 14 days duration	Healthy adults, 16 in the GoChi group, 18 in the control group	Significant improvements in energy, athletic performance, sleep quality, mental focus, contentment, calmness, and gastrointestinal regularity in the GoChi group Reduced fatigue and stress compared to placebo No significant changes in body weight, BMI, blood pressure, or pulse rate	[33]
Immune function, general well-being	Randomised, double-blind, placebo-controlled, 30 days intervention	60 healthy older adults, aged 55–72	GoChi group showed significant increases in lymphocytes, IL-2, and IgG Improved subjective well-being (reduced fatigue, improved sleep) No adverse effects or significant changes in CD4, CD8, NK cells, or body metrics	[34]
Immune response, vaccine efficacy	Randomised, double-blind, placebo-controlled, 3 months intervention	150 healthy elderly, aged 65–70	LWB group showed significantly higher postvaccination serum influenza-specific IgG and seroconversion rates No significant impact on inflammatory markers or hypersensitivity No adverse effects reported	[35]
Immune response, vaccine efficacy, antioxidant properties	Randomised, double-blind, placebo-controlled, 3 months duration	150 healthy elderly adults, aged 65–70, community-dwelling Chinese population	LWB group showed significantly higher post-vaccination serum influenza-specific IgG levels Increased seroconversion rate between days 30 and 90 No significant effects on delayed-type hypersensitivity or inflammatory markers No serious adverse effects reported	[36]
General health (sleep, energy, TCM outcomes)	Double-blind, randomised controlled	27 adults, 14 in the goji berry group (20 g/day), 13 in the control group (15.7 g green raisins/day)	No significant differences between groups in primary outcomes Slight changes in waist circumference and blood pressure over time in both groups Results indicate changes may be due to external factors or shared bioactivity between goji berries and raisins The study does not confirm health benefits specific to goji berry consumption	[37]
Oxidant stress-related conditions	Randomised, double-blind, placebo-controlled, 30 days duration	50 healthy Chinese adults, aged 55–72, GoChi (120 mL/day)	Significant increase in antioxidant markers in the GoChi group: SOD +8.4%, GSH-Px +9.9%, MDA –8.7% No significant changes in the placebo group GoChi enhanced endogenous antioxidant activity, suggesting a potential for reducing free radical-related conditions	[38]
Oxidative stress, age-related disorders	Parallel design, randomised controlled, 16 weeks duration	40 middle-aged and older adults, 22 in the wolfberry group, 18 in the control group, 15 g dried wolfberry/day	Significant increase in plasma zeaxanthin, plasma 8-iso-prostaglandin F2α, and skin carotenoids in the wolfberry group (P < 0.05) Inverse correlation between plasma zeaxanthin and plasma 8-iso-prostaglandin F2α (P = 0.05) Wolfberry consumption may help attenuate lipid peroxidation and oxidative stress in older adults	[39]
Depression, inflammatory response	Double-blinded, randomised, placebo-controlled, 6 weeks duration	29 adolescents with subthreshold depression, aged 14–16	LBP (300 mg/day) significantly reduced depressive symptoms in adolescents Decreased IL-17A levels in the LBP group LBP suppressed immune response, suggesting its antidepressant effect may be linked to reducing inflammation	[40]
Subthreshold depression	Randomised, double-blind, placebo-controlled trial	29 adolescents with subthreshold depression (15.13 ± 2.17 years)	LBP (300 mg/day) significantly reduced depressive symptoms (measured by HAMD-24) compared to placebo Higher remission rate (HAMD-24 score ≤ 7) in the LBP group No significant differences in secondary measures BDI-II, PSQI, Kessler, SCARED LBP was well tolerated with no adverse events	[41]
MDD	Double-blind, randomised, placebo-controlled, 6 weeks duration	284 estimated participants, aged 18–60 years	Ongoing study	[42]
AMD	Randomised, unmasked, parallel-arm study, 90 days duration	27 participants, aged 45–65, consuming either 28 g goji berries or a supplement (6 mg lutein and 4 mg zeaxanthin) five times weekly	Goji berry intake significantly increased MPOD at 0.25 and 1.75 retinal eccentricities (P = 0.029 and P = 0.044) Skin carotenoids significantly increased in the goji berry group at day 45 (P = 0.025) and day 90 (P = 0.006) No changes observed in the lutein/zeaxanthin group Regular goji berry intake may help prevent or delay AMD development	[43]
AMD	Single-blinded, placebo-controlled, parallel design, 28 days duration	27 healthy subjects (14 wolfberry group, 13 control), consuming 15 g wolfberry (3 mg zeaxanthin) daily	Plasma zeaxanthin levels increased 2.5-fold in the wolfberry group (0.038 µM to 0.096 µM, P < 0.01) No significant change in the control group (0.038 µM to 0.043 µM, P > 0.05) Zeaxanthin in wolfberries is bioavailable and increases fasting plasma zeaxanthin levels	[44]
Macular health	Double-masked, randomised, placebo-controlled, 90 days duration	150 healthy elderly subjects (65–70 years), 75 in the LWB group, 75 in the control group, supplemented daily with 13.7 g/day LWB or placebo	LWB supplementation stabilised macular pigmentation and prevented soft drusen accumulation Plasma zeaxanthin increased by 26% and antioxidant capacity by 57% in the LWB group (P < 0.05), with no changes in the placebo group No adverse events reported in either group	[45]
AMD	Randomised, single-blind, cross-over	12 volunteers, administered either 5 mg of esterified or non-esterified 3R,3'R-zeaxanthin, suspended in yogurt with a balanced breakfast, with a 3-week depletion period between interventions	Plasma 3R,3'R-zeaxanthin concentration increased significantly after consumption of both esterified and non-esterified forms (P = 0.05), peaking at 9–24 h Esterified 3R,3'R-zeaxanthin showed enhanced bioavailability compared to the non-esterified form No meso-zeaxanthin formation observed during the study	[46]
AMD	Double-blinded, controlled, human intervention, multiple cross-over design, 3–5 weeks washout period	12 healthy, consenting subjects, aged 21–30, administered a zeaxanthin-standardised dose (15 mg) from three wolfberry formulations (hot water, warm skimmed milk, and hot skimmed milk) in randomised order	Zeaxanthin bioavailability peaked at 6 h post-ingestion for all formulations Bioavailability from the hot milk formulation was significantly higher (P < 0.001) than the hot water and warm milk formulations Hot milk formulation showed a 3-fold enhanced bioavailability of zeaxanthin compared to the other two treatments	[47]
RP	Double-masked, placebo-controlled	42 RP patients (23 in the treatment, 19 in the control group) receiving daily L. barbarum or placebo granules for 12 months	No deterioration in visual acuity in the L. barbarum group compared to the placebo (P = 0.001) No macular thinning in the L. barbarum group (P = 0.008) No significant differences in visual field sensitivity or electroretinogram ffERG parameters	[48]
Mild hypercholesterolemia, overweight	Randomised, double-blind, parallel groups, 8 weeks duration	53 overweight and hypercholesterolemic subjects, 26 in the WBE group, 27 in the placebo group, consuming 13.5 g WBE or placebo daily	Higher proportion of deregulated mRNAs related to oxidative and inflammatory stress in the WBE group	[49]
Body weight, central adiposity	Randomised, double-blind, placebo-controlled, multiple-period crossover design	8 adult subjects (age 45 ± 5 years) with varying doses of dietary fibre (0 g, 1 g, 5 g, 10 g) and 15 mL of L. barbarum juice	L. barbarum juice increased RMR when combined with dietary fibre RMR significantly increased by 7.2% (5 g fibre) and 8.4% (10 g fibre) compared to baseline (P < 0.05)	[50]
Weight loss, waist circumference	Randomised, double-blind, placebo-controlled, 14 days intervention	15 healthy adults (aged 34 years, BMI = 29 kg/m²), multiple doses of L. barbarum	L. barbarum increased PPEE by 10% at 1 h (120 mL dose, P < 0.05) Significant reduction in waist circumference by 5.5 cm ± 0.8 cm compared to the placebo group (P < 0.01)	[51]
Obesity prevention, metabolism	Randomised, double-blind, crossover	17 healthy overweight males, aged 18–65	No significant differences in energy expenditure, respiratory quotient, glucose, triacylglycerol, and free fatty acids post-meal between L. barbarum and control meals (P > 0.05)	[52]
Metabolomics, lipid metabolism	Randomised controlled, 4 weeks duration	42 healthy male adults, LBP supplementation (300 mg/day)	Significant decrease in TG/HDL index Increased serum levels of phosphate and leucine Decreased d-talose, 3-aminoisobutyric acid, threitol, ribose, and tyrosine in urine Glycerophospholipid and tyrosine metabolism impacted by LBP supplementation	[53]
Type 2 diabetes	Randomised controlled, double-blind	67 type 2 diabetes patients, 37 in the LBP group, 30 in the control group	Significant reduction in serum glucose Increased insulinogenic index Increased HDL levels More effective hypoglycaemic effects in non-medicated patients LBP showed potential as a treatment aid for type 2 diabetes	[54]
Cardiovascular health	Parallel design, randomised controlled	40 Singaporean adults, aged 50–64	Wolfberry consumption with a healthy diet increased plasma total nitrate/nitrite and reduced endothelin-1 HDL cholesterol increased in the wolfberry group No significant changes in other cardiovascular biomarkers Wolfberry enhanced the cardiovascular benefits of a HDP	[55]
Cardiovascular health	Randomised, parallel design, 16 weeks duration	41 middle-aged and older adults	Wolfberry and control groups showed changes in 27 and 42 lipid species, respectively Significant correlations between lipid species and CVD risk factors Wolfberry increased HDL cholesterol, correlated with phosphatidylcholine species No differential CVD risk associations between groups	[56]
Immune function, antioxidant activity	Randomised controlled, 6 weeks duration	46 male taekwondo athletes, aged 18–22, 23 per group	Increased CD4+ cells, CD4+/CD8+ ratio, NK cells in the wolfberry polysaccharide group (P < 0.05) Significant improvement in IgA, IgG, and antioxidant markers (MDA, SOD, CAT) (P < 0.05) Enhanced performance in the AMCAT system evaluation for the intervention group (P < 0.05)	[57]
MS, cardiovascular health	Randomised controlled, parallel design, 45 days duration	50 MS patients, 15 males, 35 females	Significant reduction in transaminases and waist circumference in the test group Improvement in lipid profile and increased glutathione and CAT levels (P < 0.05) Reduction in lipid peroxidation in the test group	[58]
Atherosclerosis, cardiovascular health	Controlled trial comparing LBP and Qigong exercise, 3 months duration	Elderly male participants, administered LBP or engaged in Qigong exercise	LBP and Qigong exercise both reduced plasma TGs, total cholesterol, and LDL cholesterol Both increased HDL cholesterol and helped modulate blood pressure Healthy Qigong exercise had comparable effects to LBP	[59]
Cardiovascular health	16-week intervention with HDP with or without wolfberries	24 middle-aged and older adults, 9 in the HDP group, 15 in the HDP + wolfberry group	HDP improved BOEC colony growth, tube formation, and migration activity Wolfberry supplementation did not enhance BOEC function further BOEC colony number positively correlated with blood pressure, atherogenic index, vascular age, and Framingham risk score	[60]
Advanced cancer (multiple types)	Clinical trial with LAK/IL-2 + LBP combination	79 advanced cancer patients, 75 evaluable (malignant melanoma, renal cell carcinoma, colorectal carcinoma, lung cancer, nasopharyngeal carcinoma, malignant hydrothorax)	LAK/IL-2 + LBP group showed a 40.9% response rate vs. 16.1% in LAK/IL-2 only (P < 0.05) Longer remission in the LAK/IL-2 + LBP group Increased NK and LAK cell activity with LBP supplementation LBP is a potential adjuvant for cancer biotherapy	[61]
NAFLD	Randomised, double-blind, placebo-controlled	50 NAFLD patients	Ongoing trial	[62]

AMCAT: Agarose Microscopy-based Cell Assay Technology; AMD: age-related macular degeneration; BDI-II: Beck Depression Inventory-Second Edition; BMI: body mass index; BOEC: blood outgrowth endothelial cell; CAT: catalase; CVD: cardiovascular disease; ffERG: full-field electroretinography; GSH-Px: glutathione peroxidase; HAMD: Hamilton Depression Rating Scale; HDL: high-density lipoprotein; HDP: healthy dietary pattern; IgG: immunoglobulin G; IL: interleukin; Kessler: Kessler Psychological Distress Scale (K10); LAK: lymphokine-activated killer; LBP: Lycium barbarum polysaccharide; L. barbarum: Lycium barbarum; LDL: low-density lipoprotein; LWB: Lacto-Wolfberry; MDA: malondialdehyde; MDD: major depressive disorder; MPOD: macular pigment optical density; MS: metabolic syndrome; NAFLD: non-alcoholic fatty liver disease; NK: natural killer; PPEE: postprandial energy expenditure; PSQI: Pittsburgh Sleep Quality Index; RMR: resting metabolic rate; RP: retinitis pigmentosa; SCARED: Screen for Child Anxiety Related Emotional Disorders; SOD: superoxide dismutase; TCM: traditional Chinese medicine; TG: triglyceride; WBE: aqueous extract of wolfberry fruit

Immune support

Numerous studies have provided evidence of the positive effects of L. barbarum on general health and well-being, particularly when consumed as juice. For example, Amagase and Nance [33] found that standardised L. barbarum juice (GoChi) significantly improved participants’ overall health. In this pioneering study outside of China, participants who consumed 120 mL/day of GoChi (equivalent to approximately 150 g of fresh L. barbarum fruits) for 14 days exhibited enhanced well-being, improved neurological function, and better gastrointestinal health.

Building on these findings, a meta-analysis by Amagase and Hsu [63] assessed the effects of daily GoChi consumption in 161 participants aged 18–72. This study revealed significant improvements in mental acuity, sleep quality, reduced stress, and enhanced focus and energy levels. In a separate randomised, double-blind, placebo-controlled clinical trial involving older adults (aged 55–72), Amagase et al. [34] reported that 120 mL/day of L. barbarum juice for 30 days significantly boosted immune function. Participants exhibited higher lymphocyte counts and increased levels of interleukin (IL)-2 and immunoglobulin G (IgG), while no significant changes were observed in IL-4 and IgA. Importantly, no adverse reactions were reported, indicating the safety of L. barbarum juice in enhancing immune response. In a randomised, double-blind, placebo-controlled trial, Lacto-Wolfberry (LWB) supplementation over three months in elderly individuals enhanced immune response to the influenza vaccine, demonstrating significantly higher post-vaccination serum influenza-specific IgG levels compared to placebo, without serious adverse effects [35].

In another supportive study, Vidal et al. [36] assessed the effects of long-term dietary supplementation with a milk-based wolfberry preparation in 150 elderly participants (aged 65–70). The study demonstrated that consuming 13.7 g/day of LWB resulted in a higher IgG-specific antibody response, greater seroconversion, and enhanced protection following influenza vaccination compared to a placebo group. Additionally, this supplementation was associated with a lower incidence of macular hypopigmentation and soft drusen, suggesting a potential protective effect against age-related macular degeneration (AMD).

However, contrasting findings have emerged in which the study published by Gonçalves et al. [37] investigated the consumption of 20 g/day of dried L. barbarum fruit in a randomised controlled trial. The study found no significant differences between the L. barbarum group and a control group consuming 15.7 g/day of raisins, in terms of waist circumference, systolic and diastolic blood pressure. The authors speculated that these results might have been influenced by unmeasured external factors, or that raisins and L. barbarum may share similar bioactive properties. This suggests that the potential health benefits of dried L. barbarum may not be as pronounced as those seen with fresh juice or other preparations.

Antioxidant enhancement

In another investigation by Amagase et al. [38], the antioxidant effects of LBPs in GoChi juice were evaluated through a randomised, double-blind, placebo-controlled trial involving 50 healthy adults aged 55–72. Participants consumed 60 mL of GoChi twice daily for 30 days. Significant increases were observed in several antioxidant markers, including an 8.4% rise in superoxide dismutase (SOD), a 9.9% increase in glutathione peroxidase (GSH-Px), and an 8.7% elevation in malondialdehyde (MDA) levels. These findings suggest that GoChi enhances the body’s endogenous antioxidant defences, which may help prevent free radical-related conditions such as neurodegenerative diseases, cardiovascular disorders, and cancers [64].

However, the authors acknowledged several limitations, including the inadequacy of the antioxidant markers employed and a limited understanding of the bioavailability and bioactivity of the active compounds in LBPs. A longer study period is also recommended to confirm whether these benefits are sustained and clinically relevant in disease prevention [38].

Further supporting the antioxidant potential of L. barbarum, a study by Toh et al. [39] explored its effects on reducing oxidative stress in middle-aged and older adults. In this 16-week randomised controlled trial, 40 participants aged 50–64 consumed 15 g of L. barbarum daily. Significant increases were observed in plasma levels of 8-iso-prostaglandin F2α, zeaxanthin, and skin carotenoids in the test group, compared to the control group, which showed no changes. This study aligns with previous findings and highlights L. barbarum’s potential in reducing oxidative stress and lipid peroxidation, especially when consumed alongside a healthy diet [38].

Mental health

LBPs have also shown promise in improving mental health, particularly in alleviating symptoms of depression. Depression, or major depressive disorder (MDD), is currently ranked third in the global burden of disease by the World Health Organisation and is projected to become the leading cause by 2030 [65]. Subthreshold depression (StD), characterised by depressive symptoms that do not fully meet MDD criteria, is also associated with impaired social functioning [66].

Li et al. [40] investigated the effects of LBPs on StD through an anti-inflammatory mechanism. In a six-week trial involving 29 adolescents, the study demonstrated a significant reduction in depressive symptoms in the LBPs group compared to the placebo group. This reduction was associated with decreased IL-17A levels and attenuated connectivity between inflammatory factors. These findings suggest that LBPs may alleviate depressive symptoms by modulating inflammation.

Further evidence from another study by Li et al. [41] supports the efficacy of LBPs in managing StD. In this randomised, placebo-controlled trial, adolescents receiving 300 mg/day of LBPs exhibited greater reductions in Hamilton Depression Rating Scale (HAMD) scores and higher remission rates than the placebo group. However, the authors emphasised the need for larger sample sizes to corroborate these promising results. Additionally, an ongoing clinical trial (NCT04124276) is investigating the effects of LBPs on patients with MDD. This trial may provide further insights into the mental health benefits of L. barbarum and help solidify its role in managing depressive disorders [42].

Ocular health management

Clinical studies have highlighted the potential benefits of L. barbarum for eye health, particularly in the prevention and management of ocular disorders such as AMD and retinitis pigmentosa (RP).

A study by Li et al. [43] demonstrated that daily consumption of 28 g of L. barbarum berries for 90 days significantly increased macular pigment optical density (MPOD) in healthy middle-aged adults. This randomised trial involved 27 participants aged 45–65 who consumed either L. barbarum berries or a supplement containing 6 mg of lutein and 4 mg of zeaxanthin five times a week for three months. Notably, the L. barbarum group exhibited significant increases in MPOD at 0.25 and 1.75 retinal eccentricities, while the supplement group showed no changes. As low MPOD levels are associated with a higher risk of AMD [67], these findings suggest that L. barbarum berry consumption may offer protection against AMD. However, further research is required to confirm these effects and explore the long-term benefits.

Supporting these results, Cheng et al. [44] conducted a single-blind, placebo-controlled trial examining the effects of short-term supplementation with 15 g of L. barbarum berries. The study found a 2.5-fold increase in fasting plasma zeaxanthin levels post-supplementation, which has been linked to a reduced risk of late AMD [68]. Further evidence of L. barbarum’s ocular benefits comes from a double-masked, randomised, placebo-controlled trial, which assessed the effects of a proprietary goji berry formulation, LWB, on macular health. The study involved 150 elderly individuals aged 65–70 years. Participants consuming LWB for 90 days exhibited stable macular pigmentation and a significant reduction in soft drusen accumulation, alongside a 26% increase in plasma zeaxanthin levels and a 57% rise in total antioxidant capacity compared to the placebo group [45]. These findings suggest that goji berry supplementation may play a role in preserving macular integrity and overall eye health in ageing populations, although the precise mechanisms require further exploration.

The bioavailability of zeaxanthin from L. barbarum has also garnered research attention. Breithaupt et al. [46] conducted a randomised, single-blind, crossover study with 12 participants, comparing the absorption of 5 mg of non-esterified versus esterified 3R,3'R-zeaxanthin palmitate, both administered in yogurt. The results indicated that the esterified form had enhanced bioavailability, with peak concentrations occurring between 9–24 h. This emphasises the significance of the zeaxanthin formulation consumed, though further studies are required to better understand the mechanisms behind the enhanced absorption. Benzie et al. [47] expanded these findings by investigating the bioavailability of zeaxanthin from different L. barbarum berry formulations in a double-blinded, controlled human intervention trial. In this study, 12 participants consumed a zeaxanthin-standardised dose (15 mg) with a standardised breakfast. The results revealed that homogenising the berries in hot skimmed milk significantly improved zeaxanthin bioavailability, with a threefold increase compared to other methods. This outcome is particularly relevant for maintaining macular pigment and reducing the risk of AMD, highlighting the importance of optimising zeaxanthin delivery methods. A randomised cross-over study comparing the bioavailability of H- and J-aggregated zeaxanthin in 16 participants found that the J-aggregated form had 23% higher postprandial bioavailability than the H-aggregated form, although the difference was marginally significant. This suggests that aggregation forms influence carotenoid absorption, with implications for eye health [69]. Long-term supplementation trials are needed to assess the efficacy of enhanced bioavailability of zeaxanthin supplements in maintaining macular pigment density and preventing AMD [70]. Beyond AMD, L. barbarum has also shown promise in managing other eye-related diseases, such as RP. A study by Chan et al. [48] involving 42 RP patients over 12 months, found that daily L. barbarum supplementation helped preserve visual acuity and macular structure, suggesting a neuroprotective effect that may delay or minimise cone degeneration in RP patients. Another double-masked, randomised clinical trial evaluated L. barbarum treatment in retinitis RP patients, showing that six months of L. barbarum supplementation led to a modest improvement in low-contrast visual acuity and central visual sensitivity, indicating a potential neuroprotective effect on retinal function [71].

In summary, clinical studies indicate that L. barbarum may offer significant benefits for eye health, particularly in increasing MPOD, enhancing zeaxanthin bioavailability, and potentially protecting against AMD and RP. However, further research, including long-term clinical trials, is necessary to fully validate these findings and understand the mechanisms involved.

Metabolic disorders

Human trials have examined the effects of L. barbarum on various metabolic disorders, including obesity, metabolic syndrome (MS), type 2 diabetes, and hypercholesterolemia—all of which impact metabolism [72].

One such study by Lee et al. [49], a randomised, double-blind, placebo-controlled trial, involved 53 overweight and hypercholesterolemic subjects who were administered 13.5 g of L. barbarum extract over eight weeks. The trial demonstrated that L. barbarum exhibited antioxidative and anti-inflammatory effects, primarily through the modulation of mRNA expression levels, suggesting its potential to positively impact metabolic disorders.

Further supporting this, Amagase and Nance [50] conducted a randomised, double-blind, placebo-controlled trial with a multiple-period crossover design to evaluate L. barbarum’s impact on metabolic rate and body weight. The participants received varying doses of dietary dextrin (0, 1, 5, and 10 g) combined with low doses of L. barbarum juice (GoChi). The results indicated a significant increase in resting metabolic rate (RMR), with a 7.2% to 8.4% rise from baseline within 4 h post-intake. This suggests that L. barbarum, particularly in combination with indigestible dietary fibre, can enhance metabolic rate.

In a related study, Amagase and Nance [51] also explored the effects of L. barbarum juice on RMR and postprandial energy expenditure (PPEE). Participants received single bolus doses of 30 mL, 60 mL, and 120 mL of L. barbarum juice. The study found a 10% increase in PPEE at 1 h post-intake for the highest dose (120 mL). Moreover, the waist circumference of the L. barbarum group reduced significantly by 5.5 cm ± 0.8 cm compared to pre-intervention measurements, while the placebo group showed no significant change (0.9 cm ± 0.8 cm). These findings provide further evidence of L. barbarum’s beneficial effects on metabolic health.

In contrast, van den Driessche et al. [52] conducted a study with 17 healthy, overweight males and found no significant impact of L. barbarum on PPEE or substrate oxidation. Although energy expenditure increased after both L. barbarum and control meals, no differences were observed between the two groups. Moreover, L. barbarum did not affect lipid or glucose metabolism markers. The authors speculated that variations in participant characteristics, such as age or gender, might account for discrepancies between their findings and those of previous studies.

Exploring L. barbarum’s effects on a molecular level, Xia et al. [53] conducted a study integrating serum and urine metabolomics with phytochemical analysis in 42 young, healthy males. Participants received 300 mg/day of LBPs or a placebo for four weeks. The results indicated that LBP supplementation reduced the triglyceride/high-density lipoprotein (TG/HDL) ratio, a biomarker linked to cardiovascular disease (CVD) risk [73]. Lower TG/HDL ratios are associated with reduced cardiometabolic disorder risks [74]. The study also suggested that LBPs influence glycerophospholipid and tyrosine metabolism, although the underlying mechanisms remain unclear. Notably, the focus on healthy males may have limited the observation of significant biochemical changes, highlighting the need for further research in more diverse populations.

Given the rising global prevalence of obesity and its contribution to type 2 diabetes [75], the potential anti-diabetic effects of dietary supplements, including LBPs, have garnered increasing attention. Cai et al. [54] investigated the impact of LBP supplementation in 67 patients with type 2 diabetes. Participants were given capsules containing LBPs (150 mg) and microcrystalline cellulose (150 mg) twice daily for three months. The study demonstrated a significant reduction in serum glucose levels and an improvement in the insulinogenic index. Furthermore, LBP supplementation resulted in higher HDL cholesterol levels, a factor associated with a reduced risk of cardiovascular events [76].

Cardiovascular disease

L. barbarum, abundant in antioxidants such as polysaccharides, flavonoids, and carotenoids, has been widely studied for its potential cardiovascular benefits, particularly due to its ability to reduce oxidative stress, a key factor in CVD [77]. In a 16-week randomised controlled trial, Toh et al. [55] investigated the effects of L. barbarum on cardiovascular health by administering 15 g of L. barbarum fruits daily. The results demonstrated improved adherence to a healthy dietary pattern (HDP) and enhanced blood lipid profiles, including significant improvements in HDL cholesterol. Additionally, there are reductions in long-term CVD risk and vascular age compared to the control group. While both groups showed enhanced vascular tone, wolfberry supplementation further improved blood lipid profiles, suggesting its potential cardiovascular benefits. Building on this, Toh et al. [56] extended their research to examine the impact of L. barbarum on plasma lipidome in middle-aged to older adults. Daily consumption of 15 g of wolfberry for 16 weeks led to notable alterations in the plasma lipidome, which likely contributed to the cardiovascular protective effects. These changes may also explain L. barbarum’s role in reducing oxidative damage, further supporting its use in cardiovascular health management.

Similarly, Ma et al. [57] evaluated the effects of LBPs on cardiovascular health in 18–22-year-old taekwondo athletes. Participants taking 0.36 mg of LBPs twice daily for six weeks exhibited improved physical performance, enhanced antioxidant capacity, and immune function. Moreover, the study showed reductions in MDA levels, a marker of lipid peroxidation, indicating decreased oxidative stress. Elevated levels of SOD and catalase (CAT) further supported the conclusion that L. barbarum reduces oxidative stress, benefiting cardiovascular health. In a randomised controlled trial by de Souza Zanchet et al. [58], 50 patients with MS consumed 14 g of L. barbarum daily for 45 consecutive days. Results indicated reductions in abdominal fat, low-density lipoprotein (LDL) cholesterol, waist circumference, and lipid peroxidation, highlighting L. barbarum’s potential as an effective dietary supplement for CVD prevention in MS patients.

Yu et al. [59] took a more holistic approach by assessing the combined effects of LBPs and Qigong exercise in elderly participants aged 52–73. Over three months, the participants who received LBPs (100 mg/kg body weight daily) or engaged in Qigong exercise experienced reductions in diastolic blood pressure and improvements in lipid profiles. The combination of LBPs and exercise was particularly effective in lowering long-term cardiovascular risk, suggesting that lifestyle factors may enhance the cardiovascular benefits of LBPs. Xia et al. [60] explored the effects of a HDP, with or without wolfberry supplementation (15 g/day for 16 weeks), on blood outgrowth endothelial cells (BOECs) in middle-aged and older adults. While the HDP alone significantly improved BOEC colony growth, angiogenic capacity, and migration activity, wolfberry supplementation did not offer additional benefits. Interestingly, positive correlations were found between BOEC colony numbers and cardiovascular risk factors, highlighting the importance of dietary modification in enhancing endothelial function and promoting cardiovascular health.

Cancer

Interest in the anti-cancer properties of L. barbarum has increased, although human studies remain limited. In a study by Cao et al. [61], LBPs were used as an adjuvant to lymphokine-activated killer (LAK) cells and IL-2 therapy in patients with various cancers, including malignant melanoma, lung cancer, renal cell carcinoma, and colorectal carcinoma. The combination therapy resulted in a 40.9% cancer regression rate, significantly higher than the 16.1% regression observed with LAK/IL-2 therapy alone (P < 0.05). Additionally, LBPs enhanced natural killers (NKs) and LAK cell activity, indicating that LBPs may play a role in boosting the immune response against cancer cells.

Non-alcoholic fatty liver disease

NAFLD has become the most prevalent chronic liver disease globally, with growing interest in therapies targeting the gut microbiota to manage the condition [78–80]. LBPs are being explored for their potential prebiotic effects, which may positively influence gut health and, consequently, NAFLD progression [81]. While clinical studies are still scarce, a notable ongoing trial (ChiCTR2000034740) by Gao et al. [62] is investigating the effects of LBP supplementation in NAFLD patients. This randomised, double-blind, placebo-controlled study, involving 50 participants aged 45 to 59, aims to assess LBPs’ impact on NAFLD progression and gut microbiota characteristics. Although the results are not yet available, this research holds promise for establishing LBPs as a low-risk therapeutic option for NAFLD, advancing gut microbiota-targeted strategies for the disease’s management.

Side effects, toxicity, and safety

L. barbarum berries have been an integral part of Chinese traditional culture for centuries, valued both as herbal medicine and a dietary ingredient and are generally regarded as non-toxic [24]. However, as a member of the nightshade (Solanaceae) family, concerns have been raised regarding the potential presence of toxic compounds, such as tropane alkaloids (e.g., atropine) [82] and steroidal alkaloid glycosides (e.g., lyciosides A and B) [83]. Despite these principal concerns, research investigating the presence and impact of these compounds in L. barbarum remains limited. Tropane alkaloids, which are natural secondary metabolites found in various food plants, including those in the Lycium genus, appear to vary in concentration depending on the species [82]. For instance, the atropine level in L. barbarum fruits was reported at the detection limit (0.01 mg/kg), whereas fruits of L. europaeum showed atropine at significantly higher levels (0.59 mg/kg dry weight) [82]. In its assessment of L. barbarum as a food supplement, the European Food Safety Authority (EFSA) identified potential health concerns related to the presence of atropine and hyoscyamine in the fruit and peel [84]. While hyoscyamine was detected in the roots (0.25%), shoots (0.33%), and fruits (0.29%) of L. barbarum, the identified levels of atropine were considered too low to pose significant risk concern [84].

Further analysis supports the notion that L. barbarum may not accumulate these compounds at concerning levels. A study employing quantitative thin layer chromatography found no detectable levels of tropane alkaloids (e.g., L-hyoscyamine, scopolamine) or steroidal alkaloids (e.g., α-solanine, α-chaconine) in the fruits, leaves, stems, or roots of three L. barbarum varieties [85].

Research on zeaxanthin, another secondary metabolite and carotenoid known for its benefits to eye health, has consistently demonstrated its safety and lack of toxicity [32]. Subchronic toxicity studies in rats showed no adverse effects at doses as high as 400 mg/kg body weight per day [86]. Likewise, meso-zeaxanthin exhibited no toxicity in rats even at doses of up to 200 mg/kg per day [87]. Chronic studies in cynomolgus monkeys revealed no adverse events at a dose of 20 mg/kg per day [88], and high-dose supplementation in rhesus monkeys caused no ocular toxicity [89]. Genotoxicity testing using bacterial strains found no evidence of mutagenicity for either zeaxanthin or meso-zeaxanthin [86, 87]. Based on these findings, EFSA has established an acceptable daily intake of 53 mg/day for a 70 kg adult, with a recommended usage level of 2 mg/day approved by the EU Commission [88]. With great bioactive potential revealed by the LBPs presence in goji berries, excessive intake may lead to health-related issues, for which a balanced diet outweighing the risks given by LBPs from goji berries intake would be more appropriate.

Additionally, while the primary focus of this section is on the potential toxicity and safety concerns related to the metabolites of L. barbarum, it is also important to address the potential health risks associated with chemical contaminants, such as pesticides and toxic elements. Several studies have reported the presence of heavy metals in these superfruits, raising concerns about potential adverse effects on human health, particularly with long-term consumption or excessive intake. Zhang et al. [90] noticed an increased level of heavy metals (such as Pb, Cd, Cu, Zn, As) in L. barbarum samples collected from plantations in comparison with those from supermarkets, except for Ni, registering higher Ni content in samples collected from supermarkets (0.90 mg/kg ± 0.57 mg/kg). Similar trend was noticed regarding the presence of pesticides such as dichlorvos (0.02 mg/kg ± 0.03 mg/kg), omethoate (0.02 mg/kg ± 0.05 mg/kg), malathion (0.01 mg/kg ± 0.03 mg/kg), cypermethrin (0.02 mg/kg ± 0.03 mg/kg), and fenvalerate (0.88 mg/kg ± 0.70 mg/kg) in samples from plantations whereas such pesticides were not detected in those collected from supermarkets, except for dichlorvos (0.01 mg/kg ± 0.02 mg/kg) [90]. However, the levels of both pesticides and metals in analysed samples would not pose serious health risks associated with chronic exposure, as were considerably lower than the maximum residue limits [90]. Furthermore, the increased demand for L. barbarum berries is significantly influenced by the potential use of pesticides to prevent any pests and diseases that can potentially lead to a reduction in harvest and quality [91]. Therefore, the use of pesticides in foods is constantly monitored in order to satisfy with the food safety regulations [92, 93]. Nevertheless, Pan et al. [91] reported the presence of several organophosphorus pesticides (OPs), such as chlorpyrifos, diazinon, isofenphos-methyl, phorate, and profenofos that would have not been registered for use in L. barbarum berries in China, thus questioning the intended use of these pesticides in such fruits and their associated risks for human health. The levels of pesticides (difenoconazole, fluxapyroxad, fluopyram, and cyantraniliprole) were assessed through an acute and chronic risk assessment conducted for measuring the dietary pesticide residue exposure, which showed that they are directly influenced by the processing technique (such as sun or oven drying, decoction, brewing) used [94].

Apart from tropane alkaloids and chemical contaminants such as pesticides and heavy metals, allergic and anaphylactic reactions, although rare, occurred after ingestion of L. barbarum fruits. Interestingly, individuals with food allergies, especially those allergic to lipid transfer proteins would likely be at risk of developing an allergic reaction from the consumption of L. barbarum berries [95, 96]. Cross-reactivity of L. barbarum berries in conjunction with peach, tomato, nuts, and Artemisia sp. pollen was shown to occur in individuals due to the involvement of these allergic proteins [24]. Anaphylactic reactions associated with the ingestion of L. barbarum fruits are also mentioned [97].

Interactions between L. barbarum and medication are relatively unknown, in which individuals taken prescription medicine in conjunction with goji berries could be predisposed to potential health associated risks. The development of flecainide toxicity in an old woman patient was previously linked with the consumption of L. barbarum tea, taken as a preventative measure against Covid-19, thus increasing awareness among clinicians on the possible drug-herb interactions [98]. Other drug-herb interactions showed the possible effects of oral anticoagulants, such as warfarin, leading to an increased risk of bleeding when used concomitantly with L. barbarum fruits such as tea, juice, or wine [99].

Despite several side effects L. barbarum may have on human health, possibly linked to overconsumption or in conjunction with specific medication, their richness in valuable bioactive compounds can positively impact human health. Besides, pesticides, tropane alkaloids, and metals concentrations in L. barbarum berries investigated by several authors showed adherence within the maximum residue levels, in agreement with safety concerns [84, 90, 91]. However, there is a lack of toxicological data and an absence of studies in animals and humans regarding the intake of L. barbarum berries in larger quantities over a prolonged period of time [100]. Despite their increased consumption in European countries, there is no specific regulation on the intended use of L. barbarum berries. Although its health-related benefits and different applications of L. barbarum (Figure 2) as tea, production of beverages, functional ingredients in confectionary and baked goods, and milk or meat-related products, L. barbarum berries are not regulated under the EU novel food legislation [24, 101]. Moreover, caution should be taken when consumed as several studies suggested that may trigger allergic reactions, especially in chronic individuals [96].

Figure 2

Applications of Lycium barbarum berries as a functional food

Conclusion

This comprehensive review has elucidated the multifaceted health benefits of L. barbarum, a botanical known for its diverse pharmacological properties and traditional uses. L. barbarum demonstrates significant therapeutic potential across a wide range of health conditions due to their diverse biological activities. The pharmacokinetics of L. barbarum supports its efficacy in promoting antioxidant, anti-inflammatory, and immunomodulatory activities. Human studies further substantiate L. barbarum’s role in improving metabolic health, cardiovascular function, glycaemic control, and mitigating conditions such as NAFLD and cancer. In addition to its therapeutic benefits, L. barbarum’s neuroprotective, hepatoprotective, and prebiotic activities, as well as its anti-aging and ocular health effects, highlight its broad applicability in addressing chronic diseases and enhancing overall health. However, while promising, these findings also underscore the need for further clinical research, particularly large-scale, controlled studies, to better understand its mechanisms of action, optimal dosing, and long-term safety. Overall, L. barbarum offers an exciting natural intervention with considerable potential for future therapeutic applications, although more rigorous investigation is necessary to fully integrate it into modern clinical practice.

Abbreviations

AMD

age-related macular degeneration

BOEC

blood outgrowth endothelial cell

CVD

cardiovascular disease

HDL

high-density lipoprotein

HDP

healthy dietary pattern

IgG

immunoglobulin G

interleukin

L. barbarum

Lycium barbarum

L. chinense

Lycium chinense

LAK

lymphokine-activated killer

LBPs

Lycium barbarum polysaccharides

LWB

Lacto-Wolfberry

MDD

major depressive disorder

MPOD

macular pigment optical density

metabolic syndrome

NAFLD

non-alcoholic fatty liver disease

PPEE

postprandial energy expenditure

retinitis pigmentosa

StD

subthreshold depression

Declarations Acknowledgments

The authors would like to express their sincere gratitude to the School of Food Science and Environmental Health at Technological University Dublin, Grangegorman, for providing the resources and support necessary to undertake this final-year research project as part of the BSc (Hons) Pharmaceutical Healthcare programme. The authors also extend their appreciation to Mr. Rhys Walsh for his collaborative efforts and contributions to the overall project.

Author contributions

TZ: Conceptualization, Investigation, Writing—original draft, Writing—review & editing, Supervision. EAA: Investigation, Writing—original draft, Writing—review & editing, Supervision. AB and RK: Investigation, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

Yao

Heinrich

Weckerle

The genus Lycium as food and medicine: A botanical, ethnobotanical and historical review

J Ethnopharmacol 2018 212 50 66

10.1016/j.jep.2017.10.010

29042287

Wang

Tao

Zhang

Gao

Yong

et al.

Lycium ruthenicum studies: Molecular biology, Phytochemistry and pharmacology

Food Chem 2018 240 759 66

10.1016/j.foodchem.2017.08.026

28946340

Niu

Zhang

Sun

Dou

Distinct Role of Lycium barbarum L. Polysaccharides in Oxidative Stress-Related Ocular Diseases

Pharmaceuticals (Basel) 2023 16

215

10.3390/ph16020215

37259363

PMC9966716

Zhang

Teh

Wang

Zhang

Hayford

et al.

Goji Berries as a Potential Natural Antioxidant Medicine: An Insight into Their Molecular Mechanisms of Action

Oxid Med Cell Longev 2019 2019

2437397

10.1155/2019/2437397

30728882

PMC6343173

Pedro

Sánchez-Mata

Pérez-Rodríguez

Cámara

López-Colón

Bach

et al.

Qualitative and nutritional comparison of goji berry fruits produced in organic and conventional systems

Sci Hortic 2019 257

108660

10.1016/j.scienta.2019.108660

Shah

Bule

Niaz

Chapter 3.21 - Goji Berry (Lycium barbarum)— A Superfood

Nabavi

Silva

Nonvitamin and Nonmineral Nutritional Supplements Academic Press; 2019. pp. 257–64.

10.1016/B978-0-12-812491-8.00037-0

Ilić

Đuričić

Kodranov

Ušjak

Kolašinac

Milenković

et al.

Nutritional Value, Phytochemical Composition and Biological Activities of Lycium barbarum L. fruits from Serbia

Plant Foods Hum Nutr 2024 79 662 8

10.1007/s11130-024-01208-4

38961030

Potterat

Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity

Planta Med 2010 76 7 19

10.1055/s-0029-1186218

19844860

Ilić

Dodevska

Marčetić

Božić

Kodranov

Vidović

Chemical Characterization, Antioxidant and Antimicrobial Properties of Goji Berries Cultivated in Serbia

Foods 2020 9

1614

10.3390/foods9111614

33172053

PMC7694608

Islam

Badwal

Comparative studies on phenolic profiles, antioxidant capacities and carotenoid contents of red goji berry (Lycium barbarum) and black goji berry (Lycium ruthenicum)

Chem Cent J 2017 11

10.1186/s13065-017-0287-z

29086843

PMC5483215

Amagase

Farnsworth

A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji)

Food Res Int 2011 44 1702 17

10.1016/j.foodres.2011.03.027

Wang

Chen

Zeng

Liu

Dong

Chemical and Genetic Diversity of Wolfberry

Chang

RCC

Lycium Barbarum and Human Health Dordrecht

Springer Netherlands

2015 pp. 1–26.

10.1007/978-94-017-9658-3_1

Chen

Chao

Wei

Gojiberry Breeding: Current Status and Future Prospects

Soneji

Nageswara-Rao

Breeding and Health Benefits of Fruit and Nut Crops Rijeka

IntechOpen

2018

10.5772/intechopen.76388

Redgwell

Curti

Wang

Dobruchowska

Gerwig

Kamerling

et al.

Cell wall polysaccharides of Chinese Wolfberry (Lycium barbarum): Part 2. Characterisation of arabinogalactan-proteins

Carbohydr Polym 2011 84 1075 83

10.1016/j.carbpol.2010.12.071

Wenli

Shahrajabian

Therapeutic Roles of Goji Berry and Ginseng in Traditional Chinese

JNFS 2019 4 293 305

10.18502/jnfs.v4i4.1727

Tian

Liang

Liu

Ding

Zhang

Extraction, Structural Characterization, and Biological Functions of Lycium Barbarum Polysaccharides: A Review

Biomolecules 2019 9

389

10.3390/biom9090389

31438522

PMC6770593

Yao

Heinrich

Zou

Reich

Zhang

Chen

et al.

Quality Variation of Goji (Fruits of Lycium spp.) in China: A Comparative Morphological and Metabolomic Analysis

Front Pharmacol 2018 9

151

10.3389/fphar.2018.00151

29535631

PMC5834758

Jiao

Liu

Goji Berry: a Novel Nutraceutical “Superfruit” for Florida Master Gardeners: HS1391, 10/2020

EDIS 2020 2020

10.32473/edis-hs1391-2020

Yan

Zhang

et al.

A comprehensive review of goji berry processing and utilization

Food Sci Nutr 2023 11 7445 57

10.1002/fsn3.3677

38107149

PMC10724590

Wang

Liang

Fan

Cao

et al.

Changes in Metabolome and Nutritional Quality of Lycium barbarum Fruits from Three Typical Growing Areas of China as Revealed by Widely Targeted Metabolomics

Metabolites 2020 10

10.3390/metabo10020046

31991919

PMC7073637

Gupta

Pagani

Zamboni

Singh

AI-powered revolution in plant sciences: advancements, applications, and challenges for sustainable agriculture and food security

Explor Foods Foodomics 2024 2 443 59

10.37349/eff.2024.00045

Qian

Zhao

Yang

Huang

Systematic Review of Chemical Constituents in the Genus Lycium (Solanaceae)

Molecules 2017 22

911

10.3390/molecules22060911

28629116

PMC6152755

Gao

Wei

Wang

Gao

Chen

Lycium Barbarum: A Traditional Chinese Herb and A Promising Anti-Aging Agent

Aging Dis 2017 8 778 91

10.14336/AD.2017.0725

29344416

PMC5758351

Vidović

Milinčić

Marčetić

Djuriš

Ilić

Kostić

AŽ

et al.

Health Benefits and Applications of Goji Berries in Functional Food Products Development: A Review

Antioxidants (Basel) 2022 11

248

10.3390/antiox11020248

35204130

PMC8868247

Yang

Zhao

Liu

et al.

Effects of Lycium barbarum L. Polysaccharides on Vascular Retinopathy: An Insight Review

Molecules 2022 27

5628

10.3390/molecules27175628

36080395

PMC9457721

Yang

Xia

Tang

Yang

Sun

Tissue distribution of Lycium barbarum polysaccharides in rat tissue by fluorescein isothiocyanate labeling

Food Sci Hum Wellness 2022 11 837 44

10.1016/j.fshw.2022.03.004

Xia

Yang

Zhou

Tang

Yang

Liao

et al.

Pharmacokinetics and Excretion Study of Lycium barbarum Polysaccharides in Rats by FITC-Fluorescence Labeling

Foods 2021 10

2851

10.3390/foods10112851

34829132

PMC8623638

Kaneo

Uemura

Tanaka

Kanoh

Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice

Biol Pharm Bull 1997 20 181 7

10.1248/bpb.20.181

9057983

Ripari

Garrido J

Patrignani

Puppo

Salinas

Nutritional and bioactive characterization of pistachio—a review with special focus on health

Explor Foods Foodomics 2024 2 363 90

10.37349/eff.2024.00042

Liu

Fan

Zheng

Gao

et al.

Assessment of the Bioaccessibility of Carotenoids in Goji Berry (Lycium barbarum L.) in Three Forms: In Vitro Digestion Model and Metabolomics Approach

Foods 2022 11

3731

10.3390/foods11223731

36429323

PMC9689010

Hempel

Schädle

Sprenger

Heller

Carle

Schweiggert

Ultrastructural deposition forms and bioaccessibility of carotenoids and carotenoid esters from goji berries (Lycium barbarum L.)

Food Chem 2017 218 525 33

10.1016/j.foodchem.2016.09.065

27719945

Milani

Basirnejad

Shahbazi

Bolhassani

Carotenoids: biochemistry, pharmacology and treatment

Br J Pharmacol 2017 174 1290 324

10.1111/bph.13625

27638711

PMC5429337

Amagase

Nance

A randomized, double-blind, placebo-controlled, clinical study of the general effects of a standardized Lycium barbarum (Goji) Juice, GoChi^TM

J Altern Complement Med 2008 14 403 12

10.1089/acm.2008.0004

18447631

Amagase

Sun

Nance

Immunomodulatory effects of a standardized Lycium barbarum fruit juice in Chinese older healthy human subjects

J Med Food 2009 12 1159 65

10.1089/jmf.2008.0300

19857084

Vidal

Bucheli

Gao

Moulin

Shen

Wang

et al.

Immunomodulatory effects of dietary supplementation with a milk-based wolfberry formulation in healthy elderly: a randomized, double-blind, placebo-controlled trial

Rejuvenation Res 2012 15 89 97

10.1089/rej.2011.1241

22352435

Vidal

Bucheli

Moulin

Wang

Benyacoub

P513: Effect of a dietary wolfberry preparation on immune and physical status in elderly

Eur Geriatr Med 2014 5 S244 5

10.1016/S1878-7649(14)70676-X

Gonçalves

GMR

Zhao

Patel

Graf

Effect of Goji berry consumption on physiological, biochemical and traditional Chinese medicine (TCM) outcomes

Proc Nutr Soc 2018 77

E205

10.1017/S0029665118002112

Amagase

Sun

Borek

Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults

Nutr Res 2009 29 19 25

10.1016/j.nutres.2008.11.005

19185773

Toh

DWK

Lee

Zhou

Sutanto

Lee

DPS

Tan

et al.

Wolfberry (Lycium barbarum) Consumption with a Healthy Dietary Pattern Lowers Oxidative Stress in Middle-Aged and Older Adults: A Randomized Controlled Trial

Antioxidants (Basel) 2021 10

567

10.3390/antiox10040567

33917032

PMC8067708

Liu

Wang

Kong

Shao

et al.

Effects of Lycium barbarum polysaccharide on cytokines in adolescents with subthreshold depression: a randomized controlled study

Neural Regen Res 2024 19 2036 40

10.4103/1673-5374.389360

38227533

PMC11040307

Liu

Shao

Teopiz

McIntyre

et al.

Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study

Neural Regen Res 2022 17 1582 7

10.4103/1673-5374.330618

34916444

PMC8771081

Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder [Internet]

[cited 2024 Aug 14]. Available from: https://clinicaltrials.gov/study/NCT04124276

Holt

Keen

Morse

Yiu

Hackman

Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial

Nutrients 2021 13

4409

10.3390/nu13124409

34959963

PMC8708314

Cheng

Chung

Szeto

Benzie

Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial

Br J Nutr 2005 93 123 30

10.1079/bjn20041284

15705234

Bucheli

Vidal

Shen

Zhang

Miller

et al.

Goji berry effects on macular characteristics and plasma antioxidant levels

Optom Vis Sci 2011 88 257 62

10.1097/OPX.0b013e318205a18f

21169874

Breithaupt

Weller

Wolters

Hahn

Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography

Br J Nutr 2004 91 707 13

10.1079/BJN20041105

15137922

Benzie

Chung

Wang

Richelle

Bucheli

Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.)

Br J Nutr 2006 96 154 60

10.1079/bjn20061796

16870004

Chan

Lam

Choi

Lakshmanan

et al.

Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement

J Ethnopharmacol 2019 236 336 44

10.1016/j.jep.2019.03.023

30877066

Lee

Ahn

Kwon

Lee

et al.

Dietary Wolfberry Extract Modifies Oxidative Stress by Controlling the Expression of Inflammatory mRNAs in Overweight and Hypercholesterolemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

J Agric Food Chem 2017 65 309 16

10.1021/acs.jafc.6b04701

28027641

Amagase

Nance

Resting Metabolic Rate is Synergistically Stimulated by a Single Bolus Lycium barbarum Fruit Juice Intake Combined With Indigestible Dietary Fiber in Healthy Human Adults

FASEB J 2011 25

774.4

10.1096/fasebj.25.1_supplement.774.4

Amagase

Nance

Lycium barbarum increases caloric expenditure and decreases waist circumference in healthy overweight men and women: pilot study

J Am Coll Nutr 2011 30 304 9

10.1080/07315724.2011.10719973

22081616

van den Driessche

Plat

Plasqui

Mensink

A Single Dose of Goji Berries Does Not Affect Postprandial Energy Expenditure and Substrate Oxidation in Healthy, Overweight Men

J Nutr Metab 2019 2019

4057143

10.1155/2019/4057143

30918723

PMC6408998

Xia

Tang

Wang

Yang

Wang

Liu

et al.

Metabolic effects of dietary supplementation of Lycium barbarum polysaccharides on serum and urine metabolomics in a young healthy male population

J Funct Foods 2018 46 440 8

10.1016/j.jff.2018.04.060

Cai

Liu

Zuo

Huang

Song

Wang

et al.

Practical Application of Antidiabetic Efficacy of Lycium barbarum Polysaccharide in Patients with Type 2 Diabetes

Med Chem 2015 11 383 90

10.2174/1573406410666141110153858

25381995

PMC4475782

Toh

DWK

Xia

Sutanto

Low

JHM

Poh

Wang

et al.

Enhancing the cardiovascular protective effects of a healthy dietary pattern with wolfberry (Lycium barbarum): A randomized controlled trial

Am J Clin Nutr 2021 114 80 9

10.1093/ajcn/nqab062

33964853

Toh

DWK

Zhou

Cazenave-Gassiot

Choi

Burla

Bendt

et al.

Effects of wolfberry (Lycium barbarum) consumption on the human plasma lipidome and its association with cardiovascular disease risk factors: a randomized controlled trial of middle-aged and older adults

Front Nutr 2024 11

1258570

10.3389/fnut.2024.1258570

38439925

PMC10909962

Zhang

Yang

Yuan

Effects of lycium barbarum polysaccharide on the immune function and antioxidant of taekwondo athletes

Zhongguo Ying Yong Sheng Li Xue Za Zhi 2019 35 513 6. Chinese

10.12047/j.cjap.5882.2019.112

32239855

de Souza Zanchet

Nardi

de Oliveira Souza Bratti

Filippin-Monteiro

Locatelli

Lycium barbarum Reduces Abdominal Fat and Improves Lipid Profile and Antioxidant Status in Patients with Metabolic Syndrome

Oxid Med Cell Longev 2017 2017

9763210

10.1155/2017/9763210

28685012

PMC5480053

Niu

Health-promoting effect of LBP and healthy Qigong exercise on physiological functions in old subjects

Carbohydr Polym 2009 75 312 6

10.1016/j.carbpol.2008.07.030

Xia

Toh

DWK

Zharkova

Poh

Foo

RSY

et al.

Impact of following a healthy dietary pattern with co-consuming wolfberry on number and function of blood outgrowth endothelial cells from middle-aged and older adults

Food Funct 2022 13 76 90

10.1039/d1fo02369a

34882161

Cao

Yang

Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients

Zhonghua Zhong Liu Za Zhi 1994 16 428 31. Chinese

7720497

Gao

Guo

Gao

et al.

Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial

Trials 2021 22

566

10.1186/s13063-021-05529-6

34521466

PMC8439032

Amagase

Hsu

CHP

Meta-analysis of the General Effects of a Standardized Lycium barbarum Fruit Juice Shown in Randomized, Double-blind, Placebo-controlled Human Clinical Studies

FASEB J 2009 23

716.1

10.1096/fasebj.23.1_supplement.716.1

Phaniendra

Jestadi

Periyasamy

Free radicals: properties, sources, targets, and their implication in various diseases

Indian J Clin Biochem 2015 30 11 26

10.1007/s12291-014-0446-0

25646037

PMC4310837

Hao

Jia

Chen

Zou

Jiang

Subthreshold Depression: A Systematic Review and Network Meta-Analysis of Non-Pharmacological Interventions

Neuropsychiatr Dis Treat 2023 19 2149 69

10.2147/NDT.S425509

37867932

PMC10588757

Rodríguez

Nuevo

Chatterji

Ayuso-Mateos

Definitions and factors associated with subthreshold depressive conditions: a systematic review

BMC Psychiatry 2012 12

181

10.1186/1471-244X-12-181

23110575

PMC3539957

Arunkumar

Calvo

Conrady

Bernstein

What do we know about the macular pigment in AMD: the past, the present, and the future

Eye (Lond) 2018 32 992 1004

10.1038/s41433-018-0044-0

29576617

PMC5944649

Dou

Huang

et al.

Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis

Br J Nutr 2012 107 350 9

10.1017/S0007114511004260

21899805

Hempel

Fischer

Högel

Bosy-Westphal

Carle

et al.

Effect of aggregation form on bioavailability of zeaxanthin in humans: a randomised cross-over study

Br J Nutr 2017 118 698 706

10.1017/S0007114517002653

29185931

Wilson

Tharmarajah

Jia

Semba

Schaumberg

Robinson

The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis

Adv Nutr 2021 12 2244 54

10.1093/advances/nmab071

34157098

PMC8634499

Chan

Lam

CHI

Chang

Lai

JSM

et al.

Treatment of retinitis pigmentosa by Lycium barbarum

Invest Ophthalmol Vis Sci 2016 57

135

Clemente-Suárez

Martín-Rodríguez

Redondo-Flórez

López-Mora

Yáñez-Sepúlveda

Tornero-Aguilera

New Insights and Potential Therapeutic Interventions in Metabolic Diseases

Int J Mol Sci 2023 24

10672

10.3390/ijms241310672

37445852

PMC10342188

Kosmas

Rodriguez

Polanco S

Bousvarou

Papakonstantinou

Peña

Genao E

Guzman

et al.

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

Diagnostics (Basel) 2023 13

929

10.3390/diagnostics13050929

36900073

PMC10001260

Deng

Wang

Sun

Xing

Zhang

Zuo

et al.

Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke

Eur J Neurol 2017 24 283 91

10.1111/ene.13198

27862659

Hossain

Al-Mamun

Islam

Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused

Health Sci Rep 2024 7

e2004

10.1002/hsr2.2004

38524769

PMC10958528

Boekholdt

Arsenault

Hovingh

Mora

Pedersen

Larosa

et al.

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis

Circulation 2013 128 1504 12

10.1161/CIRCULATIONAHA.113.002670

23965489

PMC3807966

Yang

Yan

Zhou

Chen

Zeng

et al.

Characterization and Evaluation of Antioxidant and Anti-Inflammatory Activities of Flavonoids from the Fruits of Lycium barbarum

Foods 2022 11

306

10.3390/foods11030306

35159457

PMC8834156

Loomba

Friedman

Shulman

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Cell 2021 184 2537 64

10.1016/j.cell.2021.04.015

33989548

Loomba

Sanyal

The global NAFLD epidemic

Nat Rev Gastroenterol Hepatol 2013 10 686 90

10.1038/nrgastro.2013.171

24042449

Younossi

Koenig

Abdelatif

Fazel

Henry

Wymer

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Hepatology 2016 64 73 84

10.1002/hep.28431

26707365

Zhu

Zhou

Liu

McLean

RJC

Chu

Prebiotic, immuno-stimulating and gut microbiota-modulating effects of Lycium barbarum polysaccharide

Biomed Pharmacother 2020 121

109591

10.1016/j.biopha.2019.109591

31733576

de Nijs

Crews

Dorgelo

MacDonald

Mulder

PPJ

Emerging Issues on Tropane Alkaloid Contamination of Food in Europe

Toxins (Basel) 2023 15

10.3390/toxins15020098

36828413

PMC9961018

Wang

Sasaki

Wang

Asada

et al.

Two novel steroidal alkaloid glycosides from the seeds of Lycium barbarum

Chem Biodivers 2011 8 2277 84

10.1002/cbdv.201000293

22162165

ESCO WORKING GROUP MEMBERS

EFSA Compendium of botanicals that have been reported to contain toxic, addictive, psychotropic or other substances of concern

EFSA Supporting Publ 2009 6

281R

10.2903/j.efsa.2009.281

Kokotkiewicz

Migas

Stefanowicz

Luczkiewicz

Krauze-Baranowska

Densitometric TLC analysis for the control of tropane and steroidal alkaloids in Lycium barbarum

Food Chem 2017 221 535 40

10.1016/j.foodchem.2016.11.142

27979237

Ravi

Raghunatha

Reddy KR

Shankaranarayanan

Deshpande

Juturu

Soni

Safety evaluation of zeaxanthin concentrate (OmniXan^TM): acute, subchronic toxicity and mutagenicity studies

Food Chem Toxicol 2014 72 30 9

10.1016/j.fct.2014.06.015

24964014

Thurnham

Howard

Studies on meso-zeaxanthin for potential toxicity and mutagenicity

Food Chem Toxicol 2013 59 455 63

10.1016/j.fct.2013.06.002

23819916

Edwards

Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake

J Ophthalmol 2016 2016

3690140

10.1155/2016/3690140

26885380

PMC4738691

Khachik

London

de Moura

Johnson

Steidl

Detolla

et al.

Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque

Invest Ophthalmol Vis Sci 2006 47 5476 86

10.1167/iovs.06-0194

17122139

Zhang

Qin

Wang

Zhou

Feng

et al.

Levels and health risk assessment of pesticides and metals in Lycium barbarum L. from different sources in Ningxia, China

Sci Rep 2022 12

561

10.1038/s41598-021-04599-5

35022452

PMC8755795

Pan

Chen

Wang

Liu

Occurrence, dissipation and processing factors of multi-pesticides in goji berry

J Hazard Mater 2024 473

134696

10.1016/j.jhazmat.2024.134696

38788586

European Food Safety Authority (EFSA) Carrasco

Cabrera L

Piazza G

Dujardin

Marchese

Medina

Pastor P

The 2022 European Union report on pesticide residues in food

EFSA J 2024 22

e8753

10.2903/j.efsa.2024.8753

38655191

PMC11036314

FAS China Staff, and the Embassies of Australia, Canada, and New Zealand

Translation of Maximum Residue Limits for Pesticides in Foods. Beijing: Embassies of Australia and Canada in Beijing, USDA’s Foreign Agricultural Service; 2021 Aug. Report NO.: CH2021-0099.

Xiao

Zhu

Residue behaviors and dietary risk assessments of four field-applied pesticides in common food products derived from goji berries (Lycium barbarum L.)

Food Control 2024 163

110493

10.1016/j.foodcont.2024.110493

Larramendi

García-Abujeta

Vicario

García-Endrino

López-Matas

García-Sedeño

et al.

Goji berries (Lycium barbarum): risk of allergic reactions in individuals with food allergy

J Investig Allergol Clin Immunol 2012 22 345 50

23101309

Uasuf

Angelis E

Guagnano

Pilolli

D’Anna

Villalta

et al.

Emerging Allergens in Goji Berry Superfruit: The Identification of New IgE Binding Proteins towards Allergic Patients’ Sera

Biomolecules 2020 10

689

10.3390/biom10050689

32365614

PMC7277879

Monzón

Ballarín S

López-Matas

Sáenz

Abad D

Pérez-Cinto

Carnés

Anaphylaxis associated with the ingestion of Goji berries (Lycium barbarum)

J Investig Allergol Clin Immunol 2011 21 567 70

22312943

Guzmán

Guzmán-Moreno

Assad-Morell

Carrizales-Sepúlveda

Flecainide toxicity associated with the use of goji berries: a case report

Eur Heart J Case Rep 2021 5

ytab204

10.1093/ehjcr/ytab204

34084998

PMC8167332

Zhang

Tian

Xie

Bleeding due to a probable interaction between warfarin and Gouqizi (Lycium Barbarum L.)

Toxicol Rep 2015 2 1209 12

10.1016/j.toxrep.2015.08.011

28962463

PMC5598317

100

Superfoods - super good? [Internet]

BfR; [cited 2024 Aug 13]. Available from: https://www.bfr.bund.de/cm/349/superfoods-super-good.pdf

101

Novel and Traditional Food applications and notifications: regulations and guidance [Internet]

European Food Safety Authority – EFSA; [cited 2024 Aug 15]. Available from: https://www.efsa.europa.eu/en/applications/novel-food-traditional-food/regulationsandguidance